Evidence map›Paper›PMID 40254740›Full record

ArticleAmerican journal of men's health

Analysis of Current Status of Clinical Trial Registrations in Andrological Diseases: Insights from ClinicalTrials.gov and ICTRP Databases.

Li-Xing Lei, Ke-Cheng Li, Wen-Hao Yu, Jun-Long Feng, Hua-Nan Zhang, Mao-Ke Chen, Wen-Xuan Dong, Ji-Xuan Chen, Jie Li, Ji-Sheng Wang and 2 more

Abstract read
In one paragraph

Article in American journal of men's health. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Li-Xing LeiDepartment of Andrology, Beijing University of Chinese Medicine Affiliated Dongzhimen Hospital, Beijing, China.ORCID 0009-0008-1763-6052
Ke-Cheng LiDepartment of Andrology, Beijing University of Chinese Medicine Affiliated Dongzhimen Hospital, Beijing, China.
Wen-Hao YuThe First Clinical Medical College, Beijing University of Chinese Medicine, Beijing, China.
Jun-Long FengDepartment of Andrology, Beijing University of Chinese Medicine Affiliated Dongzhimen Hospital, Beijing, China.ORCID 0000-0001-6836-9793
Hua-Nan ZhangDepartment of Andrology, Beijing University of Chinese Medicine Affiliated Dongzhimen Hospital, Beijing, China.ORCID 0000-0002-6249-2229
Mao-Ke ChenDepartment of Andrology, Beijing University of Chinese Medicine Affiliated Dongzhimen Hospital, Beijing, China.
Wen-Xuan DongDepartment of Andrology, Beijing University of Chinese Medicine Affiliated Dongzhimen Hospital, Beijing, China.
Ji-Xuan ChenDepartment of Andrology, Beijing University of Chinese Medicine Affiliated Dongzhimen Hospital, Beijing, China.
Jie LiDepartment of Andrology, Traditional Chinese Hospital of Xiamen, Fujian, China.
Ji-Sheng WangDepartment of Andrology, Beijing University of Chinese Medicine Affiliated Dongzhimen Hospital, Beijing, China.ORCID 0000-0002-3332-076X
Liang HanDepartment of Andrology, Beijing University of Chinese Medicine Affiliated Dongzhimen Hospital, Beijing, China.
Bin WangDepartment of Andrology, Beijing University of Chinese Medicine Affiliated Dongzhimen Hospital, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aims to analyze the registration information and outcome transparency for five common andrological diseases, as well as the factors influencing result availability. A comprehensive search was performed on ClinicalTrials.gov and the International Clinical Trials Registry Platform (ICTRP) to retrieve all clinical trial registration data related to the five defined andrological diseases from the inception of these databases up to September 1, 2024. The search extracted key trial details, including status, type, intervention, and result availability. Of 8,132 trials retrieved, 642 were analyzed. Among these, 259 trials (40.34%) reported results via ClinicalTrials.gov, ICTRP, or publications, while 113 trials (17.60%) made results publicly available on ClinicalTrials.gov or ICTRP. Among the five andrological diseases, male infertility had the highest rate of result availability (37/74, 50%), whereas benign prostatic hyperplasia exhibited the lowest (71/190, 37.37%). No significant differences were found across diseases (χ

Indexed as

Clinical Trials as TopicDatabases, FactualMale Urogenital DiseasesRegistriesHumansMaleanalysisandrological diseasesClinicalTrials.govICTRPtransparency

Identifiers

PMID40254740
PMCPMC12035042

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.